Aclarion Inc. (ACON) Insider Trading

Cluster buy

6 insiders bought $126k of their own stock in 5 days.

Open-market purchases by executives and directors between Aug 13 and Aug 17. Buying is rarer than selling and says more, but it is one input, not a verdict.

Net open-market

+$177k

11 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

7 / 0

executives and directors

Last open-market buy

Aug 2026

Aug 17, 2026

Get an email when ACON's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Aug 17	Amanda M Williams Director	Bought	5,857	$2.73	$16k	29%	Form 4
Aug 14	Gregory A Gould CFO	Bought	10,000	$2.45	$25k	20%	Form 4
Aug 13	Ryan Bond Director	Bought	21,122	$2.37	$50k	38%	Form 4
Aug 13	William Wesemann Director	Bought	2,150	$2.34	$5k	10.0%	Form 4
Aug 13	David K Neal Director	Bought	7,500	$2.40	$18k	33%	Form 4
Aug 13	Brent Ness Chief Executive Officer	Bought	5,234	$2.31	$12k	4.9%	Form 4
May 12	Scott Breidbart Director	Bought	5,664	$3.18	$18k	New	Form 4
May 11	David K Neal Director	Bought	2,500	$3.10	$8k	125000%	Form 4
May 11	Brent Ness Chief Executive Officer	Bought	6,289	$3.18	$20k	57173%	Form 4
May 6	William Wesemann Director	Bought	1,562	$3.30	$5k	156200%	Form 4
Nov 26, 2025	Brent Ness Chief Executive Officer	Bought	10	$6.20	$62	1000%	Form 4

Aug 17
Amanda M Williams
Director · bought 5,857 at $2.73
$16k
29% of stake
Aug 14
Gregory A Gould
CFO · bought 10,000 at $2.45
$25k
20% of stake
Aug 13
Ryan Bond
Director · bought 21,122 at $2.37
$50k
38% of stake
Aug 13
William Wesemann
Director · bought 2,150 at $2.34
$5k
10.0% of stake
Aug 13
David K Neal
Director · bought 7,500 at $2.40
$18k
33% of stake
Aug 13
Brent Ness
Chief Executive Officer · bought 5,234 at $2.31
$12k
4.9% of stake
May 12
Scott Breidbart
Director · bought 5,664 at $3.18
$18k
New position
May 11
David K Neal
Director · bought 2,500 at $3.10
$8k
125000% of stake
May 11
Brent Ness
Chief Executive Officer · bought 6,289 at $3.18
$20k
57173% of stake
May 6
William Wesemann
Director · bought 1,562 at $3.30
$5k
156200% of stake
Nov 26, 2025
Brent Ness
Chief Executive Officer · bought 10 at $6.20
$62
1000% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ACON, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Medical Laboratories

SERASera Prognostics Inc.

BACKImac Holdings Inc.

BRTXBiorestorative Therapies Inc.

MGRXMangoceuticals, Inc.

Spot a number that looks wrong? Check it in ACON's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ACON

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.